The potency of natural substances in reducing the level of sister chromatid exchange (sce) -inducing dna lesions

Project Information

Grant agreement ID: QLK3-CT-2000-40709

Project closed

Start date 15 May 2000

End date 14 May 2001

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 30 000,00

EU contribution € 22 500,00

Coordinated by

HELIXOR HEILMITTEL GMBH & CO.
Germany

Objective

Problem: carcinogens and gyrostatic drugs likecyclophosphamid prorogue DNA damages. A water extract of Viacom album inhibits this DNA damaging effect. However, it is unknown what substances of this extract are responsible of this effect. Project-aim: To identify the DNA protecting substances in the water extract of Viacom album. Result: The result of the project will be a new or an optimised drug to preventing damaging effects of chemotherapy in tumour patients. The SME proposes villa use the results for developing a new pharmaceutical drug for cancer therapy.

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• natural sciences › biological sciences › genetics › DNA
• medical and health sciences › clinical medicine › oncology

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-3. - Key action The "Cell factory"

Call for proposal

Data not available

Funding Scheme

EAW - Exploratory awards

Coordinator

HELIXOR HEILMITTEL GMBH & CO.

• EU contribution: No data
• Address: Fischermühle ; 72344 Rosenfeld ; Germany
• Total cost: No data

Participants (1)

NOVIPHARM GESELLSCHAFT M.B.H.

Austria

• EU contribution: No data
• Address: Klagenfurter Strasse 164 ; 9210 POERTSCHACH AM WOERTHER S
• Total cost: No data